4//SEC Filing
Saund Saran 4
Accession 0001493152-21-022217
CIK 0000908259other
Filed
Sep 7, 8:00 PM ET
Accepted
Sep 8, 5:00 PM ET
Size
5.6 KB
Accession
0001493152-21-022217
Insider Transaction Report
Form 4
Saund Saran
CHIEF BUSINESS OFFICER
Transactions
- Award
Stock Options
2021-09-03+675,000→ 675,000 totalExercise: $0.14Exp: 2031-09-03→ Common Stock (675,000 underlying)
Footnotes (1)
- [F1]Stock Options vest as follows: (i) 50% of the options will vest upon the consummation of a qualifying joint venture agreement, licensing agreement, or acquisition transaction (a "Corporate Transaction"); (ii) The remaining 50% on the one-year anniversary of the consummation of a Corporate Transaction.
Documents
Issuer
Oncotelic Therapeutics, Inc.
CIK 0000908259
Entity typeother
Related Parties
1- filerCIK 0001834417
Filing Metadata
- Form type
- 4
- Filed
- Sep 7, 8:00 PM ET
- Accepted
- Sep 8, 5:00 PM ET
- Size
- 5.6 KB